Discovery & Opportunity

Know the
opportunity others
can’t see yet

Know what others can’t by connecting patient, clinical and market signals to understand the true opportunity before committing resources.

This is where epidemiology, feasibility and portfolio strategy converge. When your team can see the true patient population and the diagnostic pathway they actually travel, you commit capital with a confidence the market rarely allows.

Our ecosystem was built so you can know what others can’t: 400M+ patients, 100+ data sources, and one identity spine across the clinical and commercial real-world data ecosystem.

Discuss your use case

Book a 15 minute meeting to speak with an expert

Example

Influenza vaccination activity

Patients per
100k adults

50+4030200

Drag to compare

Why this decision matters

Every project that advances on shaky epidemiologic assumptions costs more to correct later than to validate now. Optimistic prevalence numbers on a population you cannot reach eventually show up in feasibility work and in launch forecasts. Teams who do this well quantify the opportunity with real-world evidence before investing more time and resources.

Know which types of decisions are enabled at this stage

R&D / Discovery

How many patients actually have this disease, diagnosed and undiagnosed?

Epidemiology

What does natural history look like when you follow real patients across care settings, regardless of payer switching?

Commercial Strategy

Where are the current standard of care gaps leaving patients underserved?

Portfolio Planning

How does this opportunity stack against the other programs competing for the same budget?

What conventional data may not show you

Public prevalence estimates that are years old. Sizing built on a narrow payer view, or diagnostic pathways stitched together from disconnected sources. If you have ever had to reconcile vendor patient counts that do not agree, you know how much time that takes and how little confidence it produces.

Diagram showing a limited conventional view focused on later stages of the patient journey

How our real-world data ecosystem helps you know what others can’t

Our ecosystem connects claims, labs, EHR and clinical notes for 400M+ patients in a privacy compliant manner. Cohort definitions can be built against the actual inclusion criteria you plan to use instead of proxy codes. Diagnostic latency can be measured directly. Patients whose lab or symptom signals are consistent with the disease can be identified before they receive an ICD code.

Diagram showing claims, labs, EHR and clinical notes contributing to visibility across the patient journey

Bring us your question

Ready to size the opportunity more clearly?

Bring us the patient or market question you’re trying to answer and we’ll help identify the connected signals that can sharpen the opportunity.

Size your patient opportunity

15-minute conversation with a HealthVerity expert

Know theopportunity otherscan’t see yet